PreMarket Price
PreMarket Price
Healthpeak Properties, Inc. (DOC) logo

Stock Analysis

Healthpeak Properties, Inc.DOC

Price:$18.98Market Closed+0.11%at last close

P/E 53.79×· 5Y range 48.36–325.71×· bottom 7% of history

Sector: Real Estate · Industry: Real Estate Investment Trusts

AnalystsHold26 analysts
Mkt Cap 13.09BP/E 53.8Div Yield 6.32%ROE 2.6%
Low 48.4×53.8×High 325.7×

P/E 53.8× sits at the 7th percentile of its 5.086926762491444-year history.

Cash $1.63BNet debt $8.69BDebt $10.32B

Cash covers 16% of debt · Q2 2026.

Profilev65g25p18h36q10m12

PMP Verdict

Cheap for a reason — weak fundamentals

Risks

  • Quality10
  • Profitability18
Revenue +57.6% CAGRP/E 54× · 7th pctl

Cheap for a reason — fundamentals remain weak.

Bull Case

  • ✓Revenue CAGR 57.6% — durable top-line growth
  • ✓P/E 53.8× at bottom 7% of 5-year history

What's happening with DOC

Better High-Yield Dividend Stock: Pfizer vs. Healthpeak — Yahoo, 2d agoLast big move: -3.1% on 2026-10-05

Profile

Valuation — 65/100 (Moderate) P/E vs own history: 7th pct → 25/25 FCF yield: n/a → 10/25 P/S: 4.4x → 20/25 EV/EBIT: n/a → 10/25Valuation65Growth — 25/100 (Weak) Revenue CAGR: 57.6% → 25/25 Net income CAGR: -4.0% → 0/25 EPS CAGR 5Y: -27.8% → 0/25 Fwd implied growth: -19.3% → 0/25Growth25Profitability — 18/100 (Weak) ROIC: -2.6% → 0/25 ROE: 2.6% → 5/25 Net margin: 8.2% → 13/25 Operating margin: -20.2% → 0/25Profitability18Financial Health — 36/100 (Weak) Altman Z: 0.08 → 3/25 Current ratio: 2.30 → 25/25 Interest coverage: 0.2x → 3/25 Net cash / debt: D/A 40% → 5/25Health36Quality — 10/100 (Weak) Piotroski F: 4/9 → 10/25 Beneish M: 0.95 → 0/25 FCF conversion: n/a → 0/25 Margin stability: σ 26.8% → 0/25Quality10Moat — 12/100 (Weak) ROIC >12% years: n/a → 0/25 Median gross margin: n/a → 0/25 FCF-positive years: n/a → 0/25 Worst-year net margin: worst 2.5% → 12/25Moat12

earnings quality, moat, profitability, growth and financial health lag behind.

How is each axis scored?
  • Valuation65/100 · Moderate
    • P/E vs own history (7th pct)25/25
    • FCF yield (n/a)10/25
    • P/S (4.4x)20/25
    • EV/EBIT (n/a)10/25
  • Growth25/100 · Weak
    • Revenue CAGR (57.6%)25/25
    • Net income CAGR (-4.0%)0/25
    • EPS CAGR 5Y (-27.8%)0/25
    • Fwd implied growth (-19.3%)0/25
  • Profitability18/100 · Weak
    • ROIC (-2.6%)0/25
    • ROE (2.6%)5/25
    • Net margin (8.2%)13/25
    • Operating margin (-20.2%)0/25
  • Financial Health36/100 · Weak
    • Altman Z (0.08)3/25
    • Current ratio (2.30)25/25
    • Interest coverage (0.2x)3/25
    • Net cash / debt (D/A 40%)5/25
  • Quality10/100 · Weak
    • Piotroski F (4/9)10/25
    • Beneish M (0.95)0/25
    • FCF conversion (n/a)0/25
    • Margin stability (σ 26.8%)0/25
  • Moat12/100 · Weak
    • ROIC >12% years (n/a)0/25
    • Median gross margin (n/a)0/25
    • FCF-positive years (n/a)0/25
    • Worst-year net margin (worst 2.5%)12/25

Risk Flags

  • ⚠Altman Z 0.1 — distress-zone balance sheet
  • ⚠Beneish M 0.95 — earnings-manipulation flag
  • ⚠Interest coverage 0.2× — thin debt cushion

About Healthpeak Properties, Inc.

Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.

Headquarters: DENVER, CO · Employees: 411 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
2.9B+6%
Op. Income
-595.4M-135%
Net Income
243.3M+48%
EPS
0.35+48%
Operating CF
1.2B-1%

Valuation

65B
P/E (TTM)53.8xD

Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 48.4x–325.7x · 7th pct

P/FCF126.2xD

Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield0.8%C

Grade C: LowInverse of Finnhub P/FCF (own TTM FCF unavailable)

P/S (TTM)4.44xB

Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 3.9x–28.2x · 12th pct

EV/EBITDA12.6xB

Grade B: FairEnterprise value / EBITDA (Finnhub) — capital-structure neutral

EV/Sales7.4xC

Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E66.6xD

Grade D: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio1.38xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio1.11B

Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield6.32%C

Grade C: HighTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio175.9%D

Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyBelow average · 7th pct

Profitability

18E
ROIC-2.6%D

Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE2.6%D

Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks

ROA1.2%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin8.2%C

Grade C: AverageNet Income / Revenue

Operating Margin-20.2%D

Grade D: LowTTM EBIT / TTM Revenue

Gross Margin-20.2%D

Grade D: LowGross Profit / Revenue

FCF Margin—

FCF / Revenue

True FCF Margin—

TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

25E
Revenue CAGR57.6%A

Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR-4.0%D

Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)-27.8%D

Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth-19.3%D

Grade D: Decl.Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)+213.3%D

Grade D: DilutiveShare count change over 5Y

SBC / Net Income7.1%A

Grade A: LowStock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.6%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

36D
Altman Z-Score0.08D

Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio2.30xA

Grade A: HighCurrent Assets/Liabilities

Quick Ratio2.30xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage0.2xD

Grade D: RiskyEBIT/Interest. >10 Strong

Debt Repayment—

Years to repay net debt via FCF

Net Debt/EBITNet CashA

Grade A: LowLeverage. <2x Low, >4x High

Debt/Equity1.09xC

Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt0.16xD

Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash

Quality

10E
Piotroski F-Score4/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score0.95D

Grade D: RiskyEarnings manipulation risk. < -2.22 Safe

FCF Conversion—

FCF / Net Income

Margin Stability26.8%D

Grade D: VolatileEBIT margin std deviation. Lower = stable

Capex / Revenue—

TTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.14xD

Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell —No open-market trades
Recent insider transactions
Trade dateTransactionShares
Moses Kelvin O
Filed
Tax withholding
-65
Moses Kelvin O
Filed
Grant / award
+937
Patadia Ankit B.
Filed
Tax withholding
-94
Patadia Ankit B.
Filed
Grant / award
+1.4K
Mabry Adam G
Filed
Tax withholding
-43
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
Mabry Adam G
Filed
Grant / award
+625
Johnston Shawn G
Filed
Tax withholding
-76
Johnston Shawn G
Filed
Grant / award
+1.4K
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

12E
ROIC >12% Years—

Share of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)—

Median annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years—

Share of completed fiscal years with positive free cash flow

Net Margin Floor2.5%C

Grade C: ModerateWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$0.35

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$2.36

Cash & short-term investments per share (Finnhub)

Book Value / Share$11.38

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$10.32B

Total debt obligations (short + long term)

Cash & Equiv.$1.63B

Cash and short-term investments

Net Debt$8.69B

Total Debt minus Cash. Negative = Net Cash position

Total Equity$9.50B

Shareholders' equity (book value)

Asset / Liability—

Total Assets / Total Liabilities

Market

Market Cap$13.09B

Current Market Capitalization

Beta0.98B

Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Healthpeak Properties, Inc. (DOC)

Piotroski F-Score of 4/9 indicates mixed fundamentals for Healthpeak Properties, Inc.. Altman Z-Score of 0.08 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of 0.95 is above the −1.78 flag threshold, a signal that reported earnings warrant closer scrutiny.

  • Revenue has compounded at roughly 58% annually — a strong growth profile.
  • Interest coverage of 0.2× leaves little room for earnings shocks.
  • The stock currently yields 6.3% in dividends.

See how DOC ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all DOC moves →
DateSessionPriceMoveZ-Score
Oct 5Regular18.88-3.13%-3.06
Oct 5After-hours18.88-3.13%-3.06
Oct 1Regular19.41-2.83%-3.11
Sep 21Regular20.63+1.45%2.05
Sep 21After-hours20.68+1.72%2.37

Frequently Asked Questions about DOC

What is the current Healthpeak Properties, Inc. (DOC) stock price?

DOC is trading at $18.98 at the last market close, up 0.11% on the session. PreMarketPrice tracks DOC pre-market, intraday and after-hours prices.

Is DOC stock a buy right now?

PreMarketPrice's quantitative model rates Healthpeak Properties, Inc.'s financial health at 36/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is DOC stock overvalued?

Healthpeak Properties, Inc. trades at a trailing P/E of 53.8 and our valuation score rates it 65/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Healthpeak Properties, Inc. report earnings?

No confirmed earnings date is currently scheduled for DOC. The Earnings section lists recent reports and updates as dates are announced.

What sector does Healthpeak Properties, Inc. operate in?

Healthpeak Properties, Inc. operates in the Real Estate sector, within the Real Estate Investment Trusts industry. The Related Stocks section lists sector peers for comparison.

What does Healthpeak Properties, Inc. do?

Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.

About Healthpeak Properties, Inc. (DOC) Stock

Healthpeak Properties, Inc. (DOC) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry. As of the latest update, Healthpeak Properties, Inc. is trading at $18.98, up 0.11% on the day with a market capitalization of $13.1 billion. The financial health score for DOC is 36/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for DOC stock.

DOC Stock Analysis & Key Metrics

On PreMarketPrice, you can track Healthpeak Properties, Inc. (DOC) across multiple dimensions:

Is DOC a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Healthpeak Properties, Inc. (DOC) as an investment. The financial health score of 36/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Healthpeak Properties, Inc. (DOC) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Real Estate
More Real Estate Investment Trusts stocks
Cheaper alternatives
Similar fundamentals